Qynapse

The future of neuroimaging is here.
Qynapse offers groundbreaking peace of mind by providing results you can trust.

[Qynapse @QYNAPSE]

Today, we are thrilled to announce with
@calyxai a groundbreaking partnership that enables AI-enhanced Medical Imaging Services for CNS Clinical Trials!

Find out more about our partnership below https://t.co/vS4TQRg6Oa

[Calyx @calyxai]

We’re excited to partner with @Qynapse and to add advanced analysis capabilities to our full suite of proven #MedicalImaging services. Read the announcement. https://t.co/9qLdJnN9wr #clinicaltrials #ChooseCalyx

[Qynapse @QYNAPSE]

Qynapse participe au congrès de la Société Française de Neuroradiologie #SFNR cette semaine à Lyon. Contactez-nous pour découvrir comment QyScore s’intègre dans la routine clinique du #radiologue apportant précision, fiabilité pour une prise de décision éclairée. #neuroscience

[Qynapse @QYNAPSE]

Qynapse’s symposium oral presentation is live at #ADPD2022!
QyPredict #prognostic model, shows promise in improving #clinicaltrials selection towards decliners for increased trial success probability with a single upfront screening cost.
#ai #MachineLearning #Alzheimers @adpdnet

[Qynapse @QYNAPSE]

[DAY – 1]
Tomorrow at #ADPD2022, @Jorge is hosting a symposium oral presentation focusing on the evaluation of QyPredict®, a tunable #MachineLearning #prognostic model for #Alzheimers' clinical trial enrichment
#amyloid #mci #ClinicalResearch  #healthtech #digitalhealth #ai

[Qynapse @QYNAPSE]

Visit Qynapse Poster Presentation at #ADPD2022 this week presenting promising results on the reliability of our #PET pipeline for the quantification of #amyloid plaques – a key #biomarker of #alzheimersdisease.
📍On-site Poster: #P142
📍ePoster https://t.co/QOlJTShx6L
@adpdnet

[Qynapse @QYNAPSE]

#ADPD2022 is starting next week!
Join Qynapse’s team on-site presenting a #symposium oral presentation and a #poster presentation showcasing our recent advances and evidence to our #clinicaltrials & #research solutions.
#neurodegenerative #Alzheimers #parkinsons

[Qynapse @QYNAPSE]

Today at Qynapse we wanted to highlight the disproportionate impact of some major #neurological disorders on #women and acknowledge the incredible work #women do providing #care and support across these areas.
https://t.co/klufBDwX8a
#InternationalWomensDay #IWD2022 #IWD22

[Qynapse @QYNAPSE]

Qynapse is thrilled to Qynapse to present symposium oral and poster presentations at #ADPD2022 International Conference on #Alzheimer’s and #Parkinson’s Diseases and related #neurological disorders @adpdnet in Barcelona, Spain on March 15-20.
https://t.co/eU9F3rSKIR
#AI #neuro

[Qynapse @QYNAPSE]

Do not miss Adam Schwarz’s poster presentation today at #actrimsforum in Exhibit Hall A, @PBConventionCtr
📍 [P251] Poster Session 2 on Feb 25 from 6:00-6:30pm
Results show the high reproducibility of QyScore®’s results.
#ACTRIMS #multiplesclerosis #MS #ai  #neuroradiology

[Qynapse @QYNAPSE]

Do not miss Adam Schwarz’s poster presentation today at #actrimsforum in Exhibit Hall A, @PBConventionCtr
📍 [P152] Poster Session 1 on Feb 24 from 5:30-6:00pm
Results show how QyScore® could facilitate and increase confidence in the #diagnosis and #monitoring of #MS patients.

[Qynapse @QYNAPSE]

The @ACTRIMS 2022 Forum is opening today #ACTRIMS #actrimsforum! This year event themed “Biomarkers in MS”, a unique opportunity to engage with experts in #MS on the optimization of #patientmanagement and #clinicaltrials with AI-based neuroimaging #biomarkers.
Meet our team!

[RHU SHiVA @RHU_SHiVA]

Congratulations to @Qynapse for this new publication that brings forward the imaging biomarkers identification for small vessel disease! 👏🙌⬇️
#stroke #MRI #research #cSVD #SHiVA #biomarker

[Qynapse @QYNAPSE]

Qynapse is pleased to highlight recently published validation results for QyScore® white matter hyperintensities (WMH) segmentation in NeuroImage: Clinical. Perfect timing for #ACTRIMS next week!

👉 Link to the full article: @ https://t.co/NSwcnPmHEv
#actrimsforum #MS #ai

[Qynapse @QYNAPSE]

Qynapse is thrilled to attend #ACTRIMS Forum 2022 in West Palm Beach, FL on Feb 24-26, and present new evidence on the value of QyScore® for MS #diagnosis. #ACTRIMS #actrimsforum #multiplesclerosis #MS #MSresearch #biomarkers #MRI
https://t.co/7op0K3keuv

[Qynapse @QYNAPSE]

Discover now Qynapse's latest publication in European Radiology 2022, presenting QyScore® performance results in comparison to a consensus of expert neuroradiologists. Link to the full article access: https://t.co/xLRb4NOPmH
#ai #neuroradiology #mri #precisionmedicine

[Qynapse @QYNAPSE]

Qynapse est présent aujourd'hui et demain au Congrès des Unités de soins #Alzheimer 2021 @Unitesdalzheim1 pour parler de nos solutions combinant l’#IRM et l’#IA pour apporter une précision et des résultats fiables au service du #diagnostic et des décisions cliniques.

[Qynapse @QYNAPSE]

Lot of exciting projects and partnerships coming out from #RSNA21 this week! We look forward to continuing drive the future of #neuroimaging analysis together with #physicians on the front lines of diagnosing and treating central nervous system diseases.

[Qynapse @QYNAPSE]

Don’t miss your last chance to meet Qynapse on this last day of #RSNA21 Exhibition. Stop by our booth #4161 in the AI Showcase!

#rsna2021 #technology #healthtech #digitalhealth #ai #healthcare #radiology #neuroradiology #neurology #imaging #biomarkers #aiinhealthcare

[Qynapse @QYNAPSE]

Today, come meet Dr. Adam Schwarz, our Chief Scientific Officer, during Qynapse’s #AI Theater Presentation at 2pm CT in the #RSNA21 AI Showcase!
#rsna2021 #healthtech #digitalhealth #ai #healthcare #radiology #neuroradiology  #personalizedcare #precisionmedicine